NCT00184106View on ClinicalTrials.gov

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions
Phobic Disorders
Interventions
DRUG

Seroxat, Cognitive therapy, Seroxat+ cognitive therapy

Seroxat was administered over 24 weeks 20-50 mg/d, and Cognitive therapy was provided over 12 weeks. The patients were assessed at pre, post and 1 yrs follow up

Trial Locations (1)

7491

Dept. of Psychology, NTNU, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT00184106 - RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo | Biotech Hunter | Biotech Hunter